Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05588622 · ClinicalTrials.gov registry record · NA
Meru Health Program for Cancer Patients With Depression and Anxiety
A NA study, sponsored by Meru Health.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05588622: Completed NA study, sponsored by Meru Health.
NCT05588622 is a NA study that has completed, run by Meru Health. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05588622, a NA study, has completed, sponsored by Meru Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate clinical outcomes among people with cancer who participate in a 12-week therapist-supported digital mental health intervention (DMHI) called the Meru Health Program (MHP). Study participants (N=20) will be referred to the MHP through the Cancer Support Community (CSC) Helpline and network of Gilda's Club locations. The main outcomes will be depression symptoms, anxiety symptoms, health-related quality of life (HRQoL), intervention adherence, and intervention satisfaction. The secondary objective will be to determine the acceptability of the screening and referral process from the CSC networks into the MHP. Data pertaining to implementability will be collected from study participants, MHP clinicians, and CSC staff.
Interventions
- BEHAVIORAL Meru Health Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05588622
The ClinicalTrials.gov registry entry for NCT05588622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meru Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meru Health Program is the first listed.
NCT05588622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05588622 about?
NCT05588622 is a clinical study titled "Meru Health Program for Cancer Patients With Depression and Anxiety". The primary objective of this study is to evaluate clinical outcomes among people with cancer who participate in a 12-week therapist-supported digital mental health intervention (DMHI) called the Meru Health Program (MHP). Study participants (N=20) will be referred to the MHP through the Cancer Supp...
What is the current status of trial NCT05588622?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2022-09-06. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT05588622?
The interventions under investigation include: Meru Health Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05588622?
This trial is sponsored by Meru Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.